| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/28/1997 | WO1997031111A2 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them |
| 08/28/1997 | WO1997031110A1 Traf family molecule, polynucleotide coding for the molecule, and antibody against the molecule |
| 08/28/1997 | WO1997031109A1 Meltrins |
| 08/28/1997 | WO1997031108A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | WO1997031107A2 Human serum lectin - induced apoptosis and method for detecting apoptosis |
| 08/28/1997 | WO1997031104A2 Candida albicans profilin gene |
| 08/28/1997 | WO1997031099A1 Human beta 2 integrin alpha subunit |
| 08/28/1997 | WO1997031098A1 Human chemokine polypeptides |
| 08/28/1997 | WO1997031025A1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 08/28/1997 | WO1997031023A1 Peptide derivatives |
| 08/28/1997 | WO1997031022A1 Insulin derivatives and their use |
| 08/28/1997 | WO1997031021A1 Oral calcitonin preparation and method for recovering calcitonin from eggshells |
| 08/28/1997 | WO1997031020A1 METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS |
| 08/28/1997 | WO1997031019A2 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | WO1997031018A1 Crystal structure of apopain and uses thereof |
| 08/28/1997 | WO1997031017A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 08/28/1997 | WO1997031015A1 Rat ob receptors and nucleotides encoding them |
| 08/28/1997 | WO1997031010A1 Receptor protein designated 2f1 |
| 08/28/1997 | WO1997030722A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 08/28/1997 | WO1997030716A1 Anti-helicobacter vaccine complex |
| 08/28/1997 | WO1997030712A1 METHOD FOR INHIBITING NF- kappa B ACTIVATION |
| 08/28/1997 | WO1997030587A1 Dna vaccination for induction of suppressive t cell response |
| 08/28/1997 | WO1997030581A1 Male-sterile plants |
| 08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |
| 08/28/1997 | WO1997026322A3 Methods and compositions for inhibiting hexokinase |
| 08/28/1997 | WO1997023612A3 Targeted compounds with cartilage formation-inducing and/or bone formation-inducing activity |
| 08/28/1997 | WO1997022624A3 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 08/28/1997 | WO1997020051A3 Vectors and methods for gene transfer to cells |
| 08/28/1997 | WO1997019180A3 Vector consisting of a transcriptional regulatory DNA sequence linked to a DNA sequence encoding beta-lactamase for enzyme prodrug therapy |
| 08/28/1997 | WO1997018234A3 Extraction of proteins into carbon dioxide |
| 08/28/1997 | WO1997017437A3 A chromosome 21 - derived nucleic acid encoding a novel protein, compositions and method using same |
| 08/28/1997 | WO1997016535A3 Methods for use of mpl ligands with primitive human stem cells |
| 08/28/1997 | WO1997010853A3 N2s2-type bi-functional nicotinamide chelating agents for radioactive isotopes |
| 08/28/1997 | WO1997010852A3 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes |
| 08/28/1997 | CA2247517A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | CA2247113A1 Human chemokine polypeptides |
| 08/28/1997 | CA2247068A1 Crystal structure of apopain and uses thereof |
| 08/28/1997 | CA2247025A1 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | CA2246300A1 Cell-based assay |
| 08/28/1997 | CA2246226A1 Rat ob receptors and nucleotides encoding them |
| 08/28/1997 | CA2242809A1 Peptide derivatives |
| 08/27/1997 | EP0791656A2 Platenolide synthase gene |
| 08/27/1997 | EP0791654A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
| 08/27/1997 | EP0791653A1 Human Fc-gamma receptor III |
| 08/27/1997 | EP0791603A2 Pure somatostatin antagonist and methods of use thereof |
| 08/27/1997 | EP0791602A1 A purification process of a human growth hormone |
| 08/27/1997 | EP0791601A2 An agent promoting bone formation and inhibiting bone resorption |
| 08/27/1997 | EP0791358A1 Remedy for ophthalmic diseases |
| 08/27/1997 | EP0791077A1 Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter |
| 08/27/1997 | EP0791076A1 Diagnostic method and kit for determining kell blood group genotype |
| 08/27/1997 | EP0791074A2 Method for the detection of ras oncogenes, in particular the k-ras ancogene |
| 08/27/1997 | EP0791068A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 08/27/1997 | EP0791067A2 Protein kinase npk-110 |
| 08/27/1997 | EP0791066A1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 08/27/1997 | EP0791065A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 08/27/1997 | EP0791064A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines |
| 08/27/1997 | EP0791063A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine |
| 08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
| 08/27/1997 | EP0791059A1 Production of recombinant peptides as natural hydrophobic peptide analogues |
| 08/27/1997 | EP0791055A1 Method for producing biologicals in protein-free culture |
| 08/27/1997 | EP0791013A2 Methods and compositions for screening for presynaptic calcium channel blockers |
| 08/27/1997 | EP0791011A2 Biologically active tgf-beta1 and tgf-beta2 peptides |
| 08/27/1997 | EP0791010A1 Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats |
| 08/27/1997 | EP0791009A1 Modified neuropeptide y receptors |
| 08/27/1997 | EP0790835A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 08/27/1997 | EP0790833A1 Process for identifying para cation channel modulators |
| 08/27/1997 | EP0790830A1 Trophinin and trophinin-assisting proteins |
| 08/27/1997 | EP0700437B1 Dna encoding prostaglandin receptor ep1 |
| 08/27/1997 | EP0600901B1 Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
| 08/27/1997 | EP0592586B1 Use of unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, and collagen and biomaterial thereby obtained |
| 08/27/1997 | EP0527724B1 Compositions and treatments for pneumonia in animals |
| 08/27/1997 | EP0524205B1 Live vaccines |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158134A Antibodies which activate an erythropoietin receptor |
| 08/27/1997 | CN1158089A Pegylation reagents and compounds formed therewith |
| 08/27/1997 | CN1158087A Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 08/27/1997 | CN1157829A Process for producing platelet factor-4 |
| 08/27/1997 | CN1157828A Truncated form of inhibitory kappa B protein (IKB) recombinant production and uses thereof |
| 08/27/1997 | CN1157827A Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 08/27/1997 | CN1157826A Novel, ubiquitous potassium-channel proteins and genes for the same |
| 08/27/1997 | CA2198576A1 Pharmaceutical composition which comprises hirudin, and process for preparing it |
| 08/26/1997 | US5661127 Peptide compositions with growth factor-like activity |
| 08/26/1997 | US5661126 Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression |
| 08/26/1997 | US5661124 Recombinantly produced mutant hemoglobin |
| 08/26/1997 | US5661034 Serum-free medium for tissue culture containing tissue inhibitor of metalloproteinases and method for growing cells using the medium |
| 08/26/1997 | US5661033 Gene transfer using herpes virus vectors as a tool for neuroprotection |
| 08/26/1997 | US5661025 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 08/26/1997 | US5661024 DNA encoding a human serotonic (5-HT2) receptor and uses thereof |
| 08/26/1997 | US5661023 Ion exchanging and elution to recover retroviruses for vaccines |
| 08/26/1997 | US5661019 Useful in immunoassys and for targeted labeling of proteins |
| 08/26/1997 | US5661015 Recombinant coccidiosis vaccines |
| 08/26/1997 | US5661010 Incubating entamoeba histolytica trophozoites in medium modified by elimination of l-cysteine, serum, and vitamins and addition of type i collagen and calcium |
| 08/26/1997 | US5661009 Providing host cell transformed with dna encoding a consensus human leukocyte interferon, culturing cell to effect expression of dna |
| 08/26/1997 | US5661008 Recombinant human factor VIII derivatives |
| 08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
| 08/26/1997 | US5661006 Polynucleotides genetic engineering a vaccines |
| 08/26/1997 | US5661005 Purified, isolated single-stranded dna sequence; culture product |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5661003 Dna encoding vasopressin-regulated water channel protein localized in kidney collecting tubule |